(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
7.23% $ 1.705
Live Chart Being Loaded With Signals
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 68 803.00 |
Średni wolumen | 64 717.00 |
Kapitalizacja rynkowa | 9.16M |
EPS | $0 ( 2024-04-04 ) |
Następna data zysków | ( $-0.970 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.950 |
ATR14 | $0.0330 (1.94%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Biotech Target N V | Buy | 250 000 | Common Stock |
2024-04-02 | Biotech Target N V | Buy | 769 334 | Common Warrants (right to buy) |
2024-04-02 | Biotech Target N V | Buy | 134 667 | Prefunded Warrants (right to buy) |
2024-04-02 | Lalande Kevin M. | Buy | 1 154 154 | Warrants (Right to Buy) |
2024-04-02 | Lalande Kevin M. | Buy | 402 077 | Pre-Funded Warrants (Right to Buy) |
INSIDER POWER |
---|
99.93 |
Last 98 transactions |
Buy: 16 322 736 | Sell: 222 785 |
Wolumen Korelacja
Molecular Templates Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Molecular Templates Inc Korelacja - Waluta/Towar
Molecular Templates Inc Finanse
Annual | 2023 |
Przychody: | $57.31M |
Zysk brutto: | $50.40M (87.94 %) |
EPS: | $-1.800 |
FY | 2023 |
Przychody: | $57.31M |
Zysk brutto: | $50.40M (87.94 %) |
EPS: | $-1.800 |
FY | 2022 |
Przychody: | $19.75M |
Zysk brutto: | $11.95M (60.51 %) |
EPS: | $-24.69 |
FY | 2021 |
Przychody: | $38.70M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $1.690 |
Financial Reports:
No articles found.
Molecular Templates Inc
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej